Paweł Krysinski (Paweł Krysiński)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Molecularly Imprinted

Molecular Dynamics Simulations

Top Venues

Physical chemistry chemical physics : PCCP

Chemistry & biodiversity

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Edyta Maron, Paweł Krysinski, Michał Chudy
Controlled Release of Doxorubicin from Magnetoliposomes Assisted by Low-Frequency Magnetic Field. Chemistry & biodiversity (2023)
Michał Żuk, Rafał Podgórski, Anna Ruszczyńska, Tomasz Ciach, Agnieszka Majkowska-Pilip, Aleksander Bilewicz, Paweł Krysinski
Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment. Pharmaceutics 14 (8) (2022)
Dorota Nieciecka, Aleksandra Rękorajska, Dariusz Cichy, Paulina Końska, Michał Żuk, Paweł Krysinski
Synthesis and Characterization of Magnetic Drug Carriers Modified with Tb 3+ Ions. Nanomaterials (Basel, Switzerland) 12 (5) (2022)
Przemysław Miszta, Ewa Nazaruk, Dorota Nieciecka, Mariusz Możajew, Paweł Krysinski, Renata Bilewicz, Sławomir Filipek
The EcCLC antiporter embedded in lipidic liquid crystalline films - molecular dynamics simulations and electrochemical methods. Physical chemistry chemical physics : PCCP 24 (5) (2022)
Agnieszka Walewska, Milena Krajewska, Aleksandra Stefanowska, Aleksandra Buta, Renata Bilewicz, Paweł Krysinski, Piotr Bednarczyk, Piotr Koprowski, Adam Szewczyk
Methods of Measuring Mitochondrial Potassium Channels: A Critical Assessment. International journal of molecular sciences 23 (3) (2022)
Michał Żuk, Weronika Gawęda, Agnieszka Majkowska-Pilip, Magdalena Osial, Marcin Wolski, Aleksander Bilewicz, Paweł Krysinski
Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy. Pharmaceutics 13 (11) (2021)